These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20709306)

  • 1. Botulinum toxin type A for the treatment of postamputation residual limb myokymia: a case report.
    Dave SJ; Salyer J; Desai KA
    PM R; 2010 Aug; 2(8):777-9. PubMed ID: 20709306
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolated laryngeal myokymia: diagnosis and treatment.
    Sedgh J; Statham MM; Munin MC; Small G; Rosen CA
    Laryngoscope; 2010 Oct; 120(10):2033-5. PubMed ID: 20683936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of botulinum toxin type A for the treatment of radiation therapy-induced myokymia and neuromyotonia in a dog.
    Rogatko CP; Glass EN; Kent M; Hammond JJ; de Lahunta A
    J Am Vet Med Assoc; 2016 Mar; 248(5):532-7. PubMed ID: 26885596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of facial myokymia in multiple sclerosis with botulinum toxin.
    Habek M; Adamec I; Gabelić T; Brinar VV
    Acta Neurol Belg; 2012 Dec; 112(4):423-4. PubMed ID: 22669610
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of idiopathic lower limb dystonia treated with combined botulinum toxin and phenol nerve block.
    Bianchini E; Massimiani A; Bemporad J; Giovannelli M
    Acta Neurol Belg; 2024 Jun; 124(3):1095-1097. PubMed ID: 38133850
    [No Abstract]   [Full Text] [Related]  

  • 6. Botulinum toxin type A influences stump pain after limb amputations.
    Kern U; Martin C; Scheicher S; Müller H
    J Pain Symptom Manage; 2003 Dec; 26(6):1069-70. PubMed ID: 14654254
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of botulinum toxin type A on gait and quality of life in adult post-stroke patients with lower limb spasticity: a systematic review protocol.
    Chu WH; Gupta AD
    JBI Database System Rev Implement Rep; 2016 Jun; 14(6):23-9. PubMed ID: 27532646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin to treat phantom limb pain.
    Elavarasi A; Goyal V
    Toxicon; 2021 May; 195():17-19. PubMed ID: 33610636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A for focal hyperhidrosis in leg amputees: a case report.
    Wollina U; Konrad H; Graefe T; Thiele J
    Acta Derm Venereol; 2000 May; 80(3):226-7. PubMed ID: 10954228
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy of Botulinum Toxin A on improving ease of care in the upper and lower limbs: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach.
    Baker JA; Pereira G
    Clin Rehabil; 2015 Aug; 29(8):731-40. PubMed ID: 25352614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poststroke Postural Sway Improved by Botulinum Toxin: A Multicenter Randomized Double-blind Controlled Trial.
    Kerzoncuf M; Viton JM; Pellas F; Cotinat M; Calmels P; Milhe de Bovis V; Delarque A; Bensoussan L
    Arch Phys Med Rehabil; 2020 Feb; 101(2):242-248. PubMed ID: 31469982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active upper-limb movement can be improved in hemiplegic patients by botulinum toxin injection.
    Yelnik A
    J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):357. PubMed ID: 20360163
    [No Abstract]   [Full Text] [Related]  

  • 13. Continuous facial myokymia in multiple sclerosis: treatment with botulinum toxin.
    Sedano MJ; Trejo JM; Macarrón JL; Polo JM; Berciano J; Calleja J
    Eur Neurol; 2000; 43(3):137-40. PubMed ID: 10765052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More than a black box of rehabilitation: Characterizing therapy programmes following botulinum toxin injections for spasticity in adults with stroke.
    Demetrios M; Brand C; Louie J; Khan F
    J Rehabil Med; 2016 Apr; 48(5):426-34. PubMed ID: 27097568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A for upper limb spasticity after stroke.
    Shaw L; Rodgers H
    Expert Rev Neurother; 2009 Dec; 9(12):1713-25. PubMed ID: 19951131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke.
    Santamato A; Cinone N; Panza F; Letizia S; Santoro L; Lozupone M; Daniele A; Picelli A; Baricich A; Intiso D; Ranieri M
    Drugs; 2019 Feb; 79(2):143-160. PubMed ID: 30623347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cervical dystonia with botulinum toxin in a patient with myasthenia gravis.
    Gonçalves MR; Barbosa ER; Zambon AA; Marchiori PE
    Arq Neuropsiquiatr; 1999 Sep; 57(3A):683-5. PubMed ID: 10667297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of botulinum toxin type B on stump pain and involuntary movements of the stump.
    Kern U; Martin C; Scheicher S; Müller H
    Am J Phys Med Rehabil; 2004 May; 83(5):396-9. PubMed ID: 15100632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on lower limb spasticity classified by spastic muscle echo intensity in post-stroke patients.
    Hara T; Abo M; Hara H; Kobayashi K; Shimamoto Y; Shibata Y; Sasaki N; Yamada N; Niimi M
    Int J Neurosci; 2018 May; 128(5):412-420. PubMed ID: 28985683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of botulinum toxin (BTX-A) on spasticity of the lower limb and on gait in cerebral palsy.
    Preiss RA; Condie DN; Rowley DI; Graham HK
    J Bone Joint Surg Br; 2003 Sep; 85(7):943-8. PubMed ID: 14516023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.